April 19 (Reuters) - Nabi Biopharmaceuticals (NABI.O) said it agreed to sell its Aloprim for injection product for cancer patients to Ireland-based Bioniche Teoranta for $3.7 million as part of its strategic plan.
As part of the deal, Nabi will receive $1.3 million at closing, $1.4 million at the end of 2007 and $1.0 million at the end of 2008. (Reporting by Jennifer Robin Raj in Bangalore)
WASHINGTON (Reuters) - The United States is investigating whether al Qaeda was involved in a Christmas Day attempt to blow up a passenger jet, but there is no early evidence the Nigerian suspect in the case was part of a larger plot, a senior U.S. official said on Sunday. | Video
The attraction of bombing airliners means the aviation industry has to be constantly vigilant in its fight against attackers. Full Article
With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead. Full Article
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
